After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
United Therapeutics Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of United Therapeutics Corp is $16.37B. A total of 0.25 million shares were traded on the day, compared to an average of 319.01K shares.
In the most recent transaction, BENKOWITZ MICHAEL sold 10,000 shares of UTHR for 355.15 per share on Jan 06 ’25. After the transaction, the PRESIDENT AND COO now owns 0 company shares. In a previous transaction on Dec 30 ’24, BENKOWITZ MICHAEL sold 10,000 shares at 356.68 per share. UTHR shares that PRESIDENT AND COO owns now total 0.
Among the insiders who sold shares, Mesa Nilda disposed of 255 shares on Dec 30 ’24 at a per-share price of $355.77. This resulted in the Director holding 5,528 shares of UTHR after the transaction. In another insider transaction, NILDA MESA bought 255 shares at $355.77 per share on Dec 30 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, UTHR has a high of $417.82 and a low of $208.62.
As of this writing, UTHR has an earnings estimate of $6.38 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $7.77 per share and a lower estimate of $5.03.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $136.74, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Buy with a score of 4.21.